Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancer

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Kulkarni, Anand ^a   Pillai, Raji ^b   Ezekiel, Ashley M ^a   Henner, W David ^b   Handorf, Charles R ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Pathwork Diagnostics   (United States)

Author keywords

Cancer of unknown primary; Digital pathology; Gene expression profiling; Immunohistochemistry; Metastatic cancer; Poorly differentiated cancer; Tumors of uncertain origin

Indexed keywords

FIXATIVE; FORMALDEHYDE; PARAFFIN; TUMOR MARKER;

ARTICLE; BIOPSY; CANCER OF UNKNOWN PRIMARY SITE; CHEMISTRY; COMPARATIVE STUDY; FEASIBILITY STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC SCREENING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; OBSERVER VARIATION; PATHOLOGY; PILOT STUDY; PREDICTIVE VALUE; REPRODUCIBILITY; TISSUE FIXATION;

BIOPSY; FEASIBILITY STUDIES; FEMALE; FIXATIVES; FORMALDEHYDE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS, UNKNOWN PRIMARY; OBSERVER VARIATION; PARAFFIN EMBEDDING; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84865281039     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-110     Document Type: Article

References (19)

1. Abbruzzese JL, Lenzi R, Raber MN, Pathak S, Frost P. The biology of unknown primary tumors. Semin Oncol 1993, 20(3):238-243.
2. van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 2002, 38(3):409-413. 10.1016/S0959-8049(01)00378-1, 11818207.
3. Dowell JE. Cancer from an unknown primary site. The American journal of the medical sciences 2003, 326(1):35-46. 10.1097/00000441-200307000-00006, 12861124.
4. Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004, 100(9):1776-1785. 10.1002/cncr.20202, 15112256.
5. Pavlidis N, Fizazi K. Carcinoma of unknown primary (CUP). Critical reviews in oncology/hematology 2009, 69(3):271-278. 10.1016/j.critrevonc.2008.09.005, 18977667.
6. Krishna M. Diagnosis of Metastatic Neoplasms. Arch Pathol Lab Med 2010, 134:207-215.
7. Igbokwe A, Lopez-Terrada D. Molecular Testing of Solid Tumors. Arch Pathol Lab Med 2011, 135:67-82.
8. Anderson GG, Weiss LM. Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance. Applied immunohistochemistry & molecular morphology: AIMM / official publication of the Society for Applied Immunohistochemistry 2010, 18(1):3-8. 10.1097/PAI.0b013e3181a75e6d, 23291015.
9. Monzon FA, Koen TJ. Diagnosis of Metastatic Neoplasms. Arch Pathol Lab Med 2010, 134(2):216-224.
10. Monzon FA, Dumur CI. Diagnosis of uncertain primary tumors with the Pathwork® tissue-of-origin test. Expert Rev Mol Diagn 2010, 10(1):17-25. 10.1586/erm.09.75, 20014919.
11. Greco FA, Erlander M. Molecular Classification of Cancers of Unknown Primary Site. Mol Diag Ther 2009, 13(6):367-373.
12. Handorf CR. Gene Expression Analysis and Immunohistochemistry in Evaluation of Cancer of Unknown Primary: Time for a Patient-Centered Approach. JNCCN 2011, 9:1415-1420.
13. Varadhachary GR. Carcinoma of Unknown Primary: Focused Evaluation. JNCCN 2011, 9:1406-1412.
14. Pillai R, Deeter R, Rigl CT, Nystrom JS, Miller MH, Buturovic L, Henner WD. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens. The Journal of molecular diagnostics: JMD 2011, 13(1):48-56. 10.1016/j.jmoldx.2010.11.001, 3070545, 21227394.
15. Monzon FA, Lyons-Weiler M, Buturovic LJ, Rigl CT, Henner WD, Sciulli C, Dumur CI, Medeiros F, Anderson GG. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2009, 27(15):2503-2508.
16. Hainsworth JD, Pillai R, WD H, Halks-Miller M, Lane C, Greco FA. Molecular Tumor Profiling in the Diagnosis of Patients with Carcinoma of Unknown Primary Site: Retrospective Evaluation of Gene Microarray Assay. Molecular Biomarkers & Diagnosis 2011, 2(2):1-6.
17. Grenert JP, Smith A, Ruan W, Pillai R, Wu AH. Gene expression profiling from formalin-fixed, paraffin-embedded tissue for tumor diagnosis. Clinica chimica acta; international journal of clinical chemistry 2011, 412(15-16):1462-1464.
18. Pena G, Andrade-Filho J. How does a pathologist make a diagnosis?. Arch Pathol Lab Med 2009, 133(1):124-132.
19. Kayser K. Introduction of virtual microscopy in routine surgical pathology - a hypothesis and personal view from Europe. Kayser K. Diagn Pathol 2012, 7(1):48.